Synopsis of recent research by authors named "Yu-qian Sun"
- Yu-Qian Sun's recent research primarily focuses on optimizing treatments and understanding the immunological implications of allogeneic hematopoietic stem cell transplantation (allo-HSCT) for various hematological malignancies, particularly acute myeloid leukemia (AML) and acute lymphoblastic leukemia (ALL).
- Significant findings include the development of intensified conditioning regimens, such as 'Mega-Dose' decitabine, and evaluating treatments for acute graft-versus-host disease (aGVHD) highlighting the importance of immune homeostasis changes post-transplantation.
- The studies also address the complications arising from COVID-19 in transplant recipients, the role of donor-specific antibodies in graft failure, and the benefits of haploidentical transplants, showcasing a comprehensive approach to improving patient outcomes in hematological conditions.
